OKYO · OKYO Pharma Ltd · Documents
Market Cap
$73.47M
Shares
52.48M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-09-09 | — | |
| 6-K | 2026-09-08 | — | |
| 20-F/A | 2026-08-07 | 2026-03-31 | |
| 6-K | 2026-07-28 | — | |
| 6-K | 2026-07-27 | — | |
| 6-K | 2026-07-23 | — | |
| 6-K | 2026-07-23 | — | |
| 6-K | 2026-07-22 | — | |
| 6-K | 2026-07-22 | — | |
| 6-K | 2026-07-22 | — | |
| 6-K | 2026-07-21 | — | |
| 6-K | 2026-07-21 | — | |
| 20-F | 2026-07-20 | 2026-03-31 | |
| 6-K | 2026-07-20 | — | |
| 6-K | 2026-07-08 | — | |
| 6-K | 2026-07-07 | — | |
| 6-K | 2026-05-19 | — | |
| 6-K | 2026-04-29 | — | |
| 6-K | 2026-04-07 | — | |
| 6-K | 2026-03-19 | — | |
| 6-K | 2026-03-19 | — | |
| 6-K | 2026-03-19 | — | |
| 6-K | 2026-03-18 | — | |
| 6-K | 2026-03-12 | — | |
| 6-K | 2026-02-23 | — | |
| 6-K | 2026-02-13 | — | |
| 6-K | 2026-02-13 | — | |
| 6-K | 2026-02-12 | — | |
| 6-K | 2026-02-11 | 2026-02-10 | |
| 6-K | 2026-02-11 | — | |
| 6-K | 2026-02-10 | — | |
| 6-K | 2026-01-30 | — | |
| 6-K | 2026-01-30 | — | |
| 6-K | 2026-01-28 | — | |
| 6-K | 2026-01-23 | — | |
| 6-K | 2026-01-05 | — | |
| 6-K | 2025-12-19 | — | |
| 6-K | 2025-12-15 | — | |
| 6-K | 2025-12-11 | — | |
| 6-K | 2025-12-03 | — | |
| 6-K | 2025-11-21 | — | |
| 6-K | 2025-11-18 | — | |
| 6-K | 2025-10-29 | — | |
| 6-K | 2025-10-16 | — | |
| 6-K | 2025-09-22 | — | |
| 20-F/A | 2025-08-12 | 2025-03-31 | |
| 20-F | 2025-07-18 | 2025-03-31 | |
| 6-K | 2025-07-17 | — | |
| 6-K | 2025-07-16 | — | |
| 6-K | 2025-06-11 | — |
Showing 1–50 of 159 filings